These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

918 related items for PubMed ID: 14975389

  • 1. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG, Pouwels HG, van Loon AA.
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM, Toulemonde CE, Coupier H, Guigal PM, Dinic S, Sindle T, Jessett D, Black L, Bublot M, Pardo MC, Audonnet JC.
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [Abstract] [Full Text] [Related]

  • 3. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
    Heldens JG, Pouwels HG, Derks CG, Van de Zande SM, Hoeijmakers MJ.
    Vaccine; 2010 Oct 08; 28(43):6989-96. PubMed ID: 20728523
    [Abstract] [Full Text] [Related]

  • 4. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF, Daly J, Hannant D, Wilkins J, Francis MJ.
    Vaccine; 2004 Dec 02; 23(3):418-25. PubMed ID: 15530689
    [Abstract] [Full Text] [Related]

  • 5. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R, Grimmett H, Elton D, Daly JM.
    Vet Res; 2008 Dec 02; 39(3):21. PubMed ID: 18252187
    [Abstract] [Full Text] [Related]

  • 6. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
    Heldens JG, Pouwels HG, Derks CG, Van de Zande SM, Hoeijmakers MJ.
    Vaccine; 2009 Sep 04; 27(40):5530-7. PubMed ID: 19607950
    [Abstract] [Full Text] [Related]

  • 7. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR, May MA, Peters ST, Metzger SM, Rosas CT, Osterrieder N.
    Vaccine; 2010 Jan 22; 28(4):1048-55. PubMed ID: 19897066
    [Abstract] [Full Text] [Related]

  • 8. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG, van Loon AA, van de Zande S.
    Vet J; 2007 Nov 22; 174(3):592-8. PubMed ID: 17560150
    [Abstract] [Full Text] [Related]

  • 9. Updating equine influenza strains in a combined equine influenza and herpesvirus vaccine.
    Cullinane AA.
    Vet J; 2004 Mar 22; 167(2):118-20. PubMed ID: 14975382
    [No Abstract] [Full Text] [Related]

  • 10. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):67-80. PubMed ID: 16476488
    [Abstract] [Full Text] [Related]

  • 11. Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine.
    Heldens JG, Kersten AJ, Weststrate MW, van den Hoven R.
    Vet Q; 2001 Nov 15; 23(4):210-7. PubMed ID: 11765243
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
    Paillot R, Prowse L, Donald C, Medcalf E, Montesso F, Bryant N, Watson J, Jeggo M, Elton D, Newton R, Trail P, Barnes H.
    Vet Immunol Immunopathol; 2010 Aug 15; 136(3-4):272-83. PubMed ID: 20400185
    [Abstract] [Full Text] [Related]

  • 13. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R, Kydd JH, Sindle T, Hannant D, Edlund Toulemonde C, Audonnet JC, Minke JM, Daly JM.
    Vet Immunol Immunopathol; 2006 Aug 15; 112(3-4):225-33. PubMed ID: 16621023
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N.
    Vaccine; 2006 Apr 24; 24(17):3636-45. PubMed ID: 16513225
    [Abstract] [Full Text] [Related]

  • 15. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
    Crouch CF, Daly J, Henley W, Hannant D, Wilkins J, Francis MJ.
    Vet Immunol Immunopathol; 2005 Dec 15; 108(3-4):345-55. PubMed ID: 16098611
    [Abstract] [Full Text] [Related]

  • 16. Vaccine failure caused an outbreak of equine influenza in Croatia.
    Barbic L, Madic J, Turk N, Daly J.
    Vet Microbiol; 2009 Jan 01; 133(1-2):164-71. PubMed ID: 18632226
    [Abstract] [Full Text] [Related]

  • 17. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC, Clark HJ, Clark RC, Olsen CW, Townsend HG, Lunn DP.
    Vaccine; 2006 Feb 20; 24(8):1180-90. PubMed ID: 16194586
    [Abstract] [Full Text] [Related]

  • 18. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.
    Gildea S, Sanchez Higgins MJ, Johnson G, Walsh C, Cullinane A.
    Influenza Other Respir Viruses; 2016 Sep 20; 10(5):433-7. PubMed ID: 27169603
    [Abstract] [Full Text] [Related]

  • 19. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM, Hecker R, Mutwiri G, van Drunen Littel-van den Hurk S, Babiuk LA, Townsend HG.
    Vet Immunol Immunopathol; 2006 Nov 15; 114(1-2):103-10. PubMed ID: 16950519
    [Abstract] [Full Text] [Related]

  • 20. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM, Fischer L, Baudu P, Guigal PM, Sindle T, Mumford JA, Audonnet JC.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):47-57. PubMed ID: 16580075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.